Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Poisoning by pentazocine |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Accidental pentazocine poisoning |
Causative agent (attribute) |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Intentional pentazocine poisoning |
Causative agent (attribute) |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
intoxication par la pentazocine d'intention indéterminée |
Causative agent (attribute) |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Pentazocine adverse reaction |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Allergy to pentazocine (finding) |
Causative agent (attribute) |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Pentazocine overdose |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Accidental pentazocine overdose |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Intentional pentazocine overdose |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
surdose de pentazocine d'intention indéterminée |
Causative agent (attribute) |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pentazocine hydrochloride 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Pentazocine hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Pentazocine 30mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Pentazocine 30mg/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Pentazocine (as pentazocine lactate) 50 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Aspirin + pentazocine hydrochloride 325mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Paracetamol 650mg / pentazocine hydrochloride 25mg caplet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Product containing pentazocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Pentazocine measurement |
Component |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Acetaminophen + pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Aspirin + pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Accidental poisoning by pentazocine |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Pentazocine hydrochloride |
Is a |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Intentional pentazocine poisoning |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Pentazocine lactate |
Is a |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Product containing pentazocine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Product containing pentazocine in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Pentazocine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Allergy to pentazocine (finding) |
Causative agent (attribute) |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
2 |
Product containing aspirin and pentazocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Pentazocine lactate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Pentazocine hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
|
Pentazocine (as pentazocine lactate) 50 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Product containing naloxone and pentazocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
2 |
Product containing naloxone and pentazocine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely pentazocine (as pentazocine lactate) 30 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pentazocine (as pentazocine lactate) 60 milligram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Product containing only aspirin and pentazocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Product containing only pentazocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Product containing only naloxone and pentazocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
2 |
Product containing only pentazocine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Pentazocine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Pentazocine only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Product containing only naloxone and pentazocine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
2 |
Allergy to pentazocine (finding) |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Pentazocine (as pentazocine lactate) 30 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Product containing paracetamol and pentazocine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Product containing paracetamol and pentazocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Paracetamol 650 mg and pentazocine 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Paracetamol 650 mg and pentazocine 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Product containing only paracetamol and pentazocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |
Paracetamol and pentazocine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Some |
1 |